Skip to content

Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles

Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02046317
Acronym
TUFFEN
Enrollment
12
Registered
2014-01-27
Start date
2011-05-31
Completion date
2016-11-30
Last updated
2018-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

This study aims to determine if there is any difference in the success rate of ultra-sound guided femoral nerve block performed with an echogenic needle versus a standard needle.

Detailed description

To date, the published information regarding ultrasound guided femoral nerve blocks (FNB) using echo friendly needle is very limited. More so, there is even less information regarding ultrasound guided nerve blocks using echogenic versus standard of care needles. This study hopes to add to the general knowledge of pain management in the emergency department (ED) setting and provide a unique perspective on ultrasound-guided techniques using echogenic needles to enhance accuracy and success rate of nerve blocks in ED patients. The study design will have two comparative arms; in both arms we use the same local anesthetic which is Bupivacaine 0.25% with epinephrine; in all cases a total of 15 mL will be injected around the femoral nerve. Once identified with ultrasound, 5 ml will be injected at lateral, medial, and posterior aspect of the nerve. The experimental arm will receive an FNB using an echogenic needle; and the control group will receive an FNB using standard of care needles.

Interventions

DRUGFemoral Nerve Block

Femoral Nerve Block for isolated femur fractures

The experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible.

DEVICEStandard of care needle

The control group will receive ultrasound-guided femoral nerve block using standard of care needles.

DEVICEUltrasound

The experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible. The control group will receive ultrasound-guided femoral nerve block using standard of care needles.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who present to the emergency department (ED) with isolated femur fracture (no other injuries) * Patients who are cognitively alert and are able to verbalize their pain using a visual analog scale (VAS) * Patients who are mentally competent to consent for the study * Patients who can communicate in English or Spanish

Exclusion criteria

* Gestation * Prisoners * Patients who cannot communicate in English or in Spanish * Patients who have other significant injuries besides a femur fracture * Patients who are cognitively impaired and/or unable to verbalize their pain using a visual analog scale (VAS) * Patients with allergies to local anesthetics * Patients with severe liver disease * Patients with existing peripheral neuropathies in the affected limb * Patients with history of complications from previous femoral blocks * Patients with contraindications for needle insertion at inguinal area * Local signs of infection * Patient on anticoagulants and/or with history of coagulation disorders

Design outcomes

Primary

MeasureTime frameDescription
Patient Pain LevelbaselinePain level will be measured on a numeric visual analogue scale of 0-10 with 0 being no pain and 10 being the worst pain ever.

Countries

United States

Participant flow

Participants by arm

ArmCount
Echogenic Needle
The experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible. Femoral Nerve Block: Femoral Nerve Block for isolated femur fractures Echogenic needle: The experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible. Ultrasound: The experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible. The control group will receive ultrasound-guided femoral nerve block using standard of care needles.
4
Standard of Care Needle
The control group will receive ultrasound-guided femoral nerve block using standard of care needles. Femoral Nerve Block: Femoral Nerve Block for isolated femur fractures Standard of care needle: The control group will receive ultrasound-guided femoral nerve block using standard of care needles. Ultrasound: The experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible. The control group will receive ultrasound-guided femoral nerve block using standard of care needles.
8
Total12

Baseline characteristics

CharacteristicEchogenic NeedleStandard of Care NeedleTotal
Age, Continuous51.25 years
STANDARD_DEVIATION 35.55
66.88 years
STANDARD_DEVIATION 13.7
61.67 years
STANDARD_DEVIATION 22.87
Region of Enrollment
United States
4 Participants8 Participants12 Participants
Sex: Female, Male
Female
2 Participants4 Participants6 Participants
Sex: Female, Male
Male
2 Participants4 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 40 / 8
serious
Total, serious adverse events
0 / 40 / 8

Outcome results

Primary

Patient Pain Level

Pain level will be measured on a numeric visual analogue scale of 0-10 with 0 being no pain and 10 being the worst pain ever.

Time frame: baseline

ArmMeasureValue (MEAN)Dispersion
Echogenic NeedlePatient Pain Level7.50 units on a scaleStandard Deviation 2.38
Standard of Care NeedlePatient Pain Level8.00 units on a scaleStandard Deviation 2.07
Primary

Patient Pain Level

Pain level will be measured on a numeric visual analogue scale of 0-10 with 0 being no pain and 10 being the worst pain ever.

Time frame: 60 minutes after initial femoral block

ArmMeasureValue (MEAN)Dispersion
Echogenic NeedlePatient Pain Level1.25 units on a scaleStandard Deviation 2.5
Standard of Care NeedlePatient Pain Level3.75 units on a scaleStandard Deviation 2.92

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026